BMJ 2001;323:655 ( 22 September )

Papers

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

C van Walraven, assistant professor of medicinea M M Mamdani, scientistb P S Wells, associate professor of medicinea J I Williams, vice president of researchc

a Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa Hospital - Civic Campus, Ottawa, ON, Canada K1Y 4E9, b Institute for Clinical Evaluative Sciences, Toronto, ON, Canada M4N 3M5, c Toronto Rehabilitation Institute, Toronto, ON, Canada M5G 2A2

Correspondence to: C van Walraven carlv{at}ohri.ca

Objectives: To determine the association between inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding.
Design: Retrospective cohort study from population based databases.
Setting: Ontario, Canada.
Participants: 317 824 elderly people observed for more than 130 000 person years. The patients started taking an antidepressant between 1992 and 1998 and were grouped by how much the drug inhibited serotonin reuptake. Patients were observed until they stopped the drug, had an upper gastrointestinal bleed, or died or the study ended.
Main outcome measure: Admission to hospital for acute upper gastrointestinal bleeding.
Results: Overall, 974 bleeds were observed, with an overall bleeding rate of 7.3 per 1000 person years. After controlling for age or previous gastrointestinal bleeding, the risk of bleeding significantly increased by 10.7% and 9.8%, respectively, with increasing inhibition of serotonin reuptake. Absolute differences in bleeding between antidepressant groups were greatest for octogenarians (low inhibition of serotonin reuptake, 10.6 bleeds/1000 person years v high inhibition of serotonin reuptake, 14.7 bleeds/1000 person years; number needed to harm 244) and those with previous upper gastrointestinal bleeding (low, 28.6 bleeds/1000 person years v high, 40.3 bleeds/1000 person years; number needed to harm 85).
Conclusions: After age or previous upper gastrointestinal bleeding were controlled for, antidepressants with high inhibition of serotonin reuptake increased the risk of upper gastrointestinal bleeding. These increases are clinically important for elderly patients and those with previous gastrointestinal bleeding.


What is already known on this topic
A case-control study found that the risk of upper gastrointestinal bleeding increases with intake of antidepressants that extensively inhibit serotonin reuptake

The study's validity was questioned because antidepressants were not specifically classified by the extent that they inhibit serotonin reuptake, and absolute differences in bleeding rates between antidepressants were unavailable

What this study adds
The risk of upper gastrointestinal bleeding in elderly and depressed patients increases with antidepressants having the greatest extent of inhibition of serotonin reuptake

This increased risk of bleeding is clinically important for patients with a high risk of bleeding---namely, octogenarians and those with previous upper gastrointestinal bleeding

The extent that an antidepressant inhibits serotonin reuptake should be considered when drugs are required for depression in high risk patients




© BMJ 2001

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Balancing benefits and harms in health care: Summary of webchat
Birte Twisselmann
BMJ 2004 329: 458-459. [Extract] [Full Text]

Adverse drug reactions as cause of admission to hospital: Alcohol and other non-prescribed drugs may have impact on adverse drug reactions
Edwina R L Williams and Ruth E Taylor
BMJ 2004 329: 459. [Extract] [Full Text]

Risk of upper gastrointestinal bleeding increases with inhibition of serotonin reuptake
BMJ 2001 323: 0. [Full Text]

This article has been cited by other articles:

  • Andersohn, F., Konzen, C., Bronder, E., Klimpel, A., Garbe, E. (2009). Citalopram-Induced Bleeding Due to Severe Thrombocytopenia. Psychosomatics 50: 297-298 [Abstract] [Full text]  
  • Bruce, E. C., Guo, Y., Lawson, K. C., Manatunga, A. K., Auyeung, S. F., McDonald, W. M., Rushing, N., Brown, A. R., Gilles, N., Emery, M., Bonsall, R., Porquez, J., Stowe, Z., Nemeroff, C. B., Musselman, D. L. (2008). Platelet Thromboxane A2 Secretion in Patients With Major Depression Responsive to Electroconvulsive Therapy. Psychosom. Med. 70: 319-327 [Abstract] [Full text]  
  • Steffens, D. C., Chung, H., Krishnan, K. R. R., Longstreth, W.T. Jr, Carlson, M., Burke, G. L. (2008). Antidepressant Treatment and Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study. Stroke 39: 857-862 [Abstract] [Full text]  
  • Chen, Y., Guo, J. J, Li, H., Wulsin, L., Patel, N. C (2008). Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study. The Annals of Pharmacotherapy 42: 177-184 [Abstract] [Full text]  
  • Schalekamp, T., Klungel, J H., Souverein, P. C., de Boer, A. (2008). Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins. Arch Intern Med 168: 180-185 [Abstract] [Full text]  
  • Looper, K. J. (2007). Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications. Psychosomatics 48: 1-9 [Abstract] [Full text]  
  • Salaycik, K. J., Kelly-Hayes, M., Beiser, A., Nguyen, A.-H., Brady, S. M., Kase, C. S., Wolf, P. A. (2007). Depressive Symptoms and Risk of Stroke: The Framingham Study. Stroke 38: 16-21 [Abstract] [Full text]  
  • Lotrich, F. E., Pollock, B. G. (2005). Aging and Clinical Pharmacology: Implications for Antidepressants. J Clin Pharmacol 45: 1106-1122 [Abstract] [Full text]  
  • Paton, C., Ferrier, I N. (2005). SSRIs and gastrointestinal bleeding. BMJ 331: 529-530 [Full text]  
  • Bruce, E. C., Musselman, D. L. (2005). Depression, Alterations in Platelet Function, and Ischemic Heart Disease. Psychosom. Med. 67: S34-S36 [Abstract] [Full text]  
  • Meijer, W. E. E., Heerdink, E. R., Nolen, W. A., Herings, R. M. C., Leufkens, H. G. M., Egberts, A. C. G. (2004). Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants. Arch Intern Med 164: 2367-2370 [Abstract] [Full text]  
  • Williams, E. R L, Taylor, R. E (2004). Adverse drug reactions as cause of admission to hospital: Alcohol and other non-prescribed drugs may have impact on adverse drug reactions. BMJ 329: 459-459 [Full text]  
  • Baldwin, R., Wild, R. (2004). Management of depression in later life. Adv. Psychiatr. Treat. 10: 131-139 [Abstract] [Full text]  
  • Loftis, J. M., Hauser, P. (2003). Safety of the Treatment of Interferon-Alpha-Induced Depression. Psychosomatics 44: 524-526 [Full text]  
  • Movig, K. L. L., Janssen, M. W. H. E., de Waal Malefijt, J., Kabel, P. J., Leufkens, H. G. M., Egberts, A. C. G. (2003). Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients. Arch Intern Med 163: 2354-2358 [Abstract] [Full text]  
  • Sauer, W. H., Berlin, J. A., Kimmel, S. E. (2003). Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction. Circulation 108: 32-36 [Abstract] [Full text]  
  • MacHale, S. (2002). Managing depression in physical illness. Adv. Psychiatr. Treat. 8: 297-305 [Full text]  
  • Jakovljevic, D., Tuomilehto, J. (2002). Use of Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: Is There Reason for Concern?. Stroke 33: 1448-1449 [Full text]  
  • Bak, S., Tsiropoulos, I., Kjaersgaard, J. O., Andersen, M., Mellerup, E., Hallas, J., Garcia Rodriguez, L. A., Christensen, K., Gaist, D. (2002). Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study. Stroke 33: 1465-1473 [Abstract] [Full text]  
  • (2001). Serotonin-Inhibiting Antidepressants Increase GI Bleeding Risk in Older Patients. JWatch Psychiatry 2001: 11-11 [Full text]  
  • (2001). Serotonin Reuptake Inhibitors and Upper GI Bleeding. JWatch Gastroenterology 2001: 2-2 [Full text]  
  • (2001). Serotonin-Inhibiting Antidepressants Increase GI Bleeding Risk in Older Patients. JWatch General 2001: 1-1 [Full text]  

Rapid Responses:

Read all Rapid Responses

Error
Lisa Lytle
bmj.com, 5 Oct 2001 [Full text]
Antidepressants and GI bleeding
Charles Campion-Smith
bmj.com, 17 Oct 2001 [Full text]
Re: Antidepressants and GI bleeding
Jay R Hodes
bmj.com, 20 Nov 2001 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ